Live
Endpoints NewsStructure Therapeutics reports more Phase 2 data for oral GLP-1Endpoints NewsAfter Novartis pact, macrocycle shop Unnatural Products gets $45M Series BThermo FisherFarallon Capital Management LLC Lowers Position in Thermo Fisher Scientific Inc. $TMO - MarketBeatWatersDistillate Capital Partners LLC Makes New $13.96 Million Investment in Waters Corporation $WAT - MarketBeatAgilentAgilent Technologies, Inc. $A Shares Sold by Earnest Partners LLC - MarketBeatPharmaVoice340B: When the safest move can feel like no move at all. Why “waiting” is no longer a viable strategyThermo FisherBamco Inc. NY Lowers Stake in Thermo Fisher Scientific Inc. - National TodayIlluminaBamco Inc. NY Sells 39,378 Shares of Illumina, Inc. $ILMN - National TodayIlluminaBamco Inc. NY Sells 39,378 Shares of Illumina, Inc. $ILMN - MarketBeat10x Genomics BlogTXG SEC Filings - 10X Genomics, Inc. 10-K, 10-Q, 8-K Forms - Stock TitanThermo FisherThermo Fisher Scientific Inc. (TMO) Positioned for Robust Growth on AI Integration and Acquisition Boost - Insider MonkeyAgilentCinctive Capital Management LP Cuts Position in Agilent Technologies, Inc. $A - MarketBeat
PharmaVoice Mar 16, 2026

340B: When the safest move can feel like no move at all. Why “waiting” is no longer a viable strategy

340B: When the safest move can feel like no move at all. Why “waiting” is no longer a viable strategy

Original
Body unavailable. Use the original source.

Directory

59 All